Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial infection, other or unspecified",22700,99,0.72 [0.46-1.12],0.1489369380132342
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",23310,176,0.89 [0.67-1.18],0.4257455253084559
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",23077,1126,0.98 [0.88-1.08],0.6564782283219541
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Candidiasis,23333,401,1.16 [1.01-1.33],0.0394884998469229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,22608,2940,1.02 [0.96-1.08],0.5551434960493161
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),22812,2390,0.99 [0.92-1.06],0.774048369772573
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Diarrhoea and gastroenteritis of presumed infectious origin,23096,1139,0.98 [0.89-1.08],0.6860103398154809
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Enterocolitis due to Clostridium difficile,23240,77,0.78 [0.49-1.26],0.3108914395406459
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,21795,667,1.00 [0.88-1.14],0.944678157319938
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,21059,769,0.99 [0.88-1.12],0.8876850349840947
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,21116,213,1.00 [0.79-1.26],0.972305374207926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,16371,1378,1.01 [0.92-1.10],0.8754740243478702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,20929,308,1.04 [0.87-1.26],0.6507057842308216
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,23281,1324,1.00 [0.91-1.10],0.995300365290138
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Mycoses,23386,454,1.14 [0.99-1.30],0.0631107672108503
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,22745,794,1.01 [0.90-1.14],0.8325526077486632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,23337,736,0.98 [0.86-1.11],0.740520779865113
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,22133,176,0.89 [0.68-1.18],0.432049085754119
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other infectious diseases,23442,38,1.30 [0.87-1.94],0.2035409351670376
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other septicaemia,23247,646,1.02 [0.89-1.16],0.8084763085039719
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,23237,74,1.02 [0.70-1.49],0.9144826711072352
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Other viral diseases,23357,159,1.21 [0.98-1.49],0.078271109241859
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",23342,144,1.20 [0.96-1.49],0.1107360765043718
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,22242,291,0.85 [0.68-1.07],0.1630873064504827
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral agents as the cause of diseases classified to other chapters,22170,219,0.97 [0.77-1.23],0.8158503014986465
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral and other specified intestinal infections,22053,96,1.18 [0.89-1.57],0.2552978527724784
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral hepatitis,23419,33,1.24 [0.79-1.96],0.3477152467931926
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,23375,138,0.71 [0.49-1.03],0.0748529837417184
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Viral warts,23275,38,1.10 [0.67-1.79],0.7135566301174443
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter I Certain infectious and parasitic diseases,Zoster [herpes zoster],23308,71,0.49 [0.26-0.91],0.0232925593075892
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm,23206,203,0.92 [0.71-1.18],0.5035673353602572
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,23352,59,0.97 [0.62-1.51],0.8871092611354136
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,23344,59,1.03 [0.68-1.57],0.8864250071722449
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",23198,1018,0.94 [0.84-1.05],0.2459926897820709
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of meninges,23417,72,1.15 [0.83-1.60],0.387603867238435
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,23383,59,0.88 [0.54-1.43],0.6081287636515962
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of other and unspecified endocrine glands,23412,112,1.06 [0.78-1.43],0.7264618844511244
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm of ovary,23372,146,0.84 [0.61-1.16],0.2946275142872766
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Ascending colon,23423,227,1.00 [0.80-1.24],0.968101996162624
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Caecum,23428,205,0.78 [0.58-1.04],0.0868413004414823
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",23363,53,0.83 [0.48-1.42],0.4887179757063375
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Descending colon,23427,125,0.94 [0.68-1.29],0.6979250380808832
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Rectum,23389,230,0.80 [0.61-1.04],0.0955702798160095
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,23348,427,1.03 [0.88-1.20],0.7368318357562544
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Benign neoplasm: Transverse colon,23428,243,1.07 [0.87-1.30],0.522541193251115
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Carcinoma in situ of breast,18997,118,0.98 [0.72-1.34],0.9038775982745434
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Carcinoma in situ of breast, intraductal",19065,134,0.77 [0.54-1.11],0.1586914189896481
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",19061,30,0.84 [0.41-1.72],0.6354308690076369
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Diffuse large B-cell lymphoma, excluding all cancers (controls excluding all cancers)",19088,57,1.30 [0.95-1.79],0.1061102704110446
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",23382,120,1.05 [0.79-1.40],0.7362442129712261
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Haemangioma, any site",23383,118,1.07 [0.81-1.42],0.6294151521898211
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Leiomyoma of uterus,22591,487,1.03 [0.90-1.19],0.6422013305583263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lung cancer and mesothelioma,16825,274,0.98 [0.80-1.21],0.8752858718859859
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Lymphoid leukaemia,19064,33,1.16 [0.71-1.89],0.557533834309939
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",19182,151,1.02 [0.78-1.32],0.8993134024172225
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of bladder, excluding all cancers (controls excluding all cancers)",19124,93,1.05 [0.75-1.47],0.7728720967298472
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of corpus uteri, excluding all cancers (controls excluding all cancers)",19195,164,1.10 [0.87-1.38],0.4425212176935702
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of intrahepatic ducts, biliary tract and gallbladder, excluding all cancers (controls excluding all cancers)",19090,59,0.99 [0.63-1.54],0.956162173996056
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)",19090,59,0.96 [0.60-1.53],0.863304807358698
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of oesophagus, excluding all cancers (controls excluding all cancers)",19078,47,1.47 [1.09-1.98],0.0114881075784301
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of ovary, excluding all cancers (controls excluding all cancers)",19159,128,1.04 [0.78-1.38],0.7875613208108502
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of pancreas, excluding all cancers (controls excluding all cancers)",19122,91,0.78 [0.50-1.21],0.2690640804538869
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of rectum, excluding all cancers (controls excluding all cancers)",19103,72,0.94 [0.62-1.43],0.7886379946005685
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Malignant neoplasm of stomach, excluding all cancers (controls excluding all cancers)",19066,35,0.74 [0.36-1.53],0.4129752874696331
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Malignant neoplasms of independent (primary) multiple sites,19101,70,1.39 [1.08-1.79],0.0094045762931498
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi,23213,204,1.01 [0.81-1.26],0.9395497468413936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanocytic naevi of trunk,23402,69,1.22 [0.91-1.64],0.1900444667428111
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Melanoma in situ,19060,77,1.15 [0.83-1.58],0.3949113643674049
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-follicular lymphoma, hilmo, excluding all cancers",19102,71,1.25 [0.93-1.70],0.1444767809565268
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",19162,131,1.18 [0.93-1.50],0.1732546039768875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Non-small cell lung cancer, excluding all cancers (controls excluding all cancers)",19229,198,1.07 [0.85-1.34],0.5815831953260584
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other and unspecified types of non-Hodgkin lymphoma, hilmo, excluding all cancers",19112,81,1.13 [0.81-1.56],0.4746357541175815
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,Other benign neoplasms of skin,23252,146,1.12 [0.88-1.42],0.3570337372087782
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",19814,783,1.01 [0.90-1.14],0.8644890305523221
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",19847,816,1.02 [0.91-1.14],0.7237788547551284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,23160,330,1.13 [0.97-1.32],0.1168873321424265
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Anaemia in chronic diseases classified elsewhere,21738,81,0.62 [0.37-1.06],0.0801282921171436
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of spleen,22899,69,1.13 [0.79-1.61],0.5036037573607612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,22569,2514,1.01 [0.95-1.08],0.6837110658577272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Folate deficiency anaemia,22068,27,1.26 [0.77-2.07],0.3574420711460875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Idiopathic thrombocytopenic purpura,23101,44,0.76 [0.40-1.44],0.4000299721643897
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,22943,1286,0.99 [0.91-1.09],0.9076064411249116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,22943,1286,0.99 [0.91-1.09],0.9076064411249116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified aplastic anaemias,21724,67,0.80 [0.49-1.31],0.3801450877899943
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,23091,1050,1.05 [0.96-1.16],0.292559608065443
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other coagulation defects,23158,101,0.94 [0.67-1.34],0.7475250582256774
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other diseases of blood and blood-forming organs,22874,44,0.89 [0.51-1.56],0.6815747067670876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other disorders of white blood cells,22884,54,0.72 [0.39-1.31],0.2776458521529624
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,23259,202,1.02 [0.81-1.28],0.861910526652713
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Sarcoidosis,23347,51,1.31 [0.94-1.82],0.1124228541899321
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",23230,173,1.10 [0.88-1.37],0.4096485992668536
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Vitamin B12 deficiency anaemia,22147,106,0.90 [0.63-1.29],0.5641182197461532
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,18901,201,1.17 [0.96-1.42],0.1199807171733883
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Acute alcohol intoxication,22214,57,1.04 [0.67-1.60],0.8721378209959232
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alcohol dependence,22211,54,1.30 [0.95-1.79],0.1051224334197402
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Alkalosis,18743,43,1.01 [0.62-1.64],0.9839575258900904
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Bipolar affective disorders,21494,51,0.72 [0.39-1.33],0.2947739125225832
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Deficiency of other B group vitamins,21209,200,0.88 [0.67-1.15],0.3531607136835012
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Delirium, not induced by alcohol and other psychoactive substances",23066,415,0.90 [0.75-1.09],0.2725731359096928
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in Alzheimer disease,22904,253,0.96 [0.77-1.20],0.7339445835647804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Dementia in other diseases classified elsewhere,22712,61,0.80 [0.48-1.36],0.4118377740448646
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression,23118,1675,1.04 [0.96-1.12],0.3823141977212069
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Depression or dysthymia,20777,1637,1.04 [0.96-1.13],0.3281331845353388
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of lipoprotein metabolism, unspecified",18745,45,0.65 [0.33-1.31],0.2298411040507685
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorder of thyroid, unspecified",20852,101,1.08 [0.79-1.46],0.6384218921926539
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of calcium metabolism,18936,236,0.88 [0.69-1.13],0.3227755789632689
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of iron metabolism,18743,43,0.77 [0.41-1.44],0.4112520634317337
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,21382,2682,0.97 [0.91-1.04],0.350642232679127
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of magnesium metabolism,18879,179,0.90 [0.68-1.19],0.454915361441688
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of mineral metabolism,19161,461,0.95 [0.81-1.12],0.5746619937818468
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,23361,304,1.01 [0.84-1.23],0.8858709419417063
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of parathyroid gland,23197,140,1.06 [0.82-1.39],0.6428906719827507
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of phosphorus metabolism and phosphatases,18783,83,1.19 [0.88-1.59],0.25368363162836
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",18749,49,0.90 [0.53-1.52],0.6854234421091066
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,22692,1941,1.03 [0.95-1.11],0.476586008288606
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,18869,169,0.98 [0.75-1.28],0.8931256888851675
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperkalaemia,18870,170,1.19 [0.97-1.47],0.0956755638909212
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",19157,457,1.03 [0.88-1.20],0.6935743263252533
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperosmolality and hypernatraemia,18766,66,0.92 [0.58-1.45],0.7053681839359696
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hyperparathyroidism,23191,134,1.06 [0.80-1.39],0.6899318306974738
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypo-osmolality and hyponatraemia,19218,518,0.99 [0.85-1.15],0.8769873267637495
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Hypokalaemia,19174,474,1.00 [0.85-1.16],0.9594055515696216
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Iron deficiency,21070,61,1.31 [0.97-1.77],0.0796484583296095
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,22699,3999,0.98 [0.92-1.03],0.3718317727091125
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic multinodular goitre,20813,62,0.86 [0.53-1.41],0.5522359522684315
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Nontoxic single thyroid nodule,20827,76,0.79 [0.49-1.26],0.3220269271536443
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,23279,1754,0.99 [0.91-1.08],0.8219100671087061
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",23283,1753,0.99 [0.91-1.08],0.8139303206656933
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other and/or unspecified nontoxic goitre,20823,72,0.52 [0.28-0.95],0.033145229086398
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other anxiety disorders,23089,1345,1.05 [0.97-1.15],0.2395081571531997
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",19967,1267,1.03 [0.94-1.13],0.5430452445612315
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other disorders of glucose regulation and pancreatic internal secretion,23432,152,1.02 [0.77-1.34],0.914321562211966
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Other mental disorders due to brain damage and dysfunction and to physical disease,22691,40,0.89 [0.48-1.63],0.7014281724087695
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Panic disorder,21861,117,1.04 [0.78-1.40],0.7706178742092562
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Phobic anxiety disorders,21914,170,0.96 [0.73-1.25],0.7527424145833232
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases","Postprocedural endocrine and metabolic disorders, not elsewhere classified",18918,218,1.11 [0.91-1.35],0.3024048055200725
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,21892,119,1.20 [0.94-1.54],0.1338375853584636
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with neurological complications,1441,37,0.92 [0.50-1.68],0.7833225175251208
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with ophthalmic complications,1537,150,1.26 [0.99-1.60],0.0613839984557813
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with peripheral circulatory complications,21797,24,1.34 [0.82-2.18],0.2450531993221965
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes with renal complications,1425,22,1.55 [0.94-2.55],0.0867270624358877
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,23036,1263,0.96 [0.87-1.06],0.4213098271503303
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Unspecified dementia,22940,289,0.93 [0.74-1.15],0.4858314147850143
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Vitamin D deficiency,21421,412,0.75 [0.60-0.92],0.0069435886097216
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,19297,597,0.94 [0.81-1.09],0.4344929936193312
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",23360,205,0.88 [0.67-1.14],0.326867560195135
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Abdominal aortic aneurysm (AAA),22558,43,0.78 [0.41-1.49],0.4506396521267676
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Angina pectoris,22152,735,1.09 [0.97-1.22],0.1355043572168593
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Aortic aneurysm,22592,77,0.96 [0.64-1.43],0.8307297357866876
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Arterial embolism and thrombosis of lower extremity artery,22543,28,1.40 [0.89-2.21],0.1492446785889898
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Atherosclerosis, excluding cerebral and coronary sclerosis",22654,139,1.00 [0.75-1.34],0.9730087339989008
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,15247,1235,0.98 [0.89-1.08],0.7040503691553583
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,AV-block,20571,205,1.14 [0.93-1.40],0.1998626258149994
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",23401,260,0.88 [0.70-1.11],0.2880873058493783
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiac arrest,14118,106,0.98 [0.69-1.38],0.8928774629993251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cardiomyopathy,20485,119,0.64 [0.42-0.98],0.0408102856667527
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Cardiomyopathy, other and unspecified",20438,72,0.51 [0.28-0.94],0.0312626234360836
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Cerebral atherosclerosis,23439,27,1.33 [0.84-2.13],0.2269482738401791
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Conduction disorders,20975,609,1.03 [0.90-1.17],0.6610132628855714
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,22671,1265,0.99 [0.90-1.09],0.9028811578780214
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Death due to cardiac causes,21110,6213,1.01 [0.96-1.05],0.7592542408016925
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,DVT of lower extremities,22171,218,0.87 [0.67-1.12],0.2773748638034274
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Endocarditis,20412,46,0.74 [0.40-1.40],0.3610709681804394
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Heart failure, strict",23355,705,1.02 [0.90-1.16],0.7488213149389484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertension,21636,5228,1.03 [0.99-1.08],0.1716818537169593
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, essential",21643,5235,1.03 [0.99-1.08],0.1770321091776515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, portal",23342,35,0.84 [0.43-1.64],0.6143066908861835
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",16555,147,1.05 [0.79-1.39],0.7550026940332931
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,16471,63,0.87 [0.54-1.42],0.581458267780027
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Hypotension,23329,900,0.92 [0.82-1.04],0.1794483875329579
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Intracerebral haemorrhage,22796,84,0.85 [0.55-1.30],0.4512350882943789
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",22844,1427,0.96 [0.88-1.06],0.4188914322523276
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",23175,391,1.00 [0.84-1.19],0.995032983204632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Left bundle-branch block,20624,258,1.03 [0.84-1.26],0.7946436566744787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Major coronary heart disease event,23258,513,0.88 [0.75-1.04],0.1433399599437665
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",21825,408,0.83 [0.68-1.01],0.0626871891087322
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",23419,76,1.08 [0.76-1.54],0.6559101451743412
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Myocardial infarction, without ST-elevation",23434,203,0.95 [0.74-1.22],0.6750230111477651
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Oesophageal varices,21987,34,0.73 [0.35-1.53],0.4029025902254991
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other aneurysm,22565,50,0.60 [0.31-1.19],0.1451647390282994
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arrhythmias,20678,312,0.86 [0.69-1.07],0.16593293864407
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other arterial embolism and thrombosis,22573,58,1.14 [0.77-1.67],0.5076917378828476
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,22684,169,1.15 [0.92-1.43],0.2228544376822454
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other diseases of pericardium,20511,145,1.04 [0.80-1.36],0.7822830874971819
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other disorders of veins,22028,75,0.84 [0.53-1.32],0.4387495360722984
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other embolism and thrombosis,21994,41,1.13 [0.72-1.77],0.5987498805953447
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other intracranial haemorrhages,22370,32,1.15 [0.69-1.91],0.6009663646296897
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other noninfective disorders of lymphatic vessels and lymph nodes,22088,135,0.92 [0.68-1.26],0.6165573760727338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,21027,661,1.02 [0.90-1.17],0.719212811691517
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,22465,36,0.76 [0.38-1.54],0.4523474481503338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,22953,438,0.94 [0.80-1.12],0.4912418248621043
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,22940,279,1.09 [0.90-1.31],0.3812855495946284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Other specified cerebrovascular diseases, other cerebrovascular disorders in diseases classified elsewhere",22795,457,0.94 [0.79-1.12],0.4862433049945799
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,14260,248,1.00 [0.81-1.25],0.9640302287563428
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Peripheral artery disease,22746,241,0.87 [0.67-1.11],0.2578970105587906
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),22234,281,0.87 [0.70-1.09],0.2351213400796169
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Pulmonary embolism,23040,379,0.96 [0.81-1.15],0.6872995455371977
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,23371,489,1.01 [0.87-1.17],0.9193663270411024
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Right bundle-branch block,20543,177,0.95 [0.73-1.24],0.7220962629414727
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Secondary right heart disease,22934,273,1.10 [0.92-1.33],0.2948005047870691
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Sequelae of cerebrovascular disease,22471,133,1.12 [0.87-1.45],0.3769901466019205
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",23167,455,0.97 [0.82-1.14],0.7111358305595183
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,"Stroke, including SAH",23145,495,0.98 [0.84-1.14],0.787175452818325
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Subarachnoid haemorrhage,22767,62,0.90 [0.57-1.43],0.6593724418191755
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Thoracic aortic aneurysm,22550,35,0.80 [0.40-1.60],0.5351317958244688
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Transient ischemic attack,22961,177,0.98 [0.76-1.27],0.8922868073513357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Unstable angina pectoris,22918,173,1.04 [0.81-1.33],0.7430652862247842
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Varicose veins,22321,368,0.88 [0.73-1.08],0.2190016712231801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Vascular diseases of the intestine,22526,83,0.77 [0.48-1.22],0.2587010851981094
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter IX Diseases of the circulatory system,Venous thromboembolism,23261,600,0.92 [0.79-1.07],0.2704657793287593
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",23403,194,1.05 [0.84-1.31],0.6744813129175347
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",20820,1571,1.03 [0.95-1.12],0.4630800863241782
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Any mental disorder,22933,3684,1.01 [0.96-1.07],0.6589406453113945
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",23378,227,1.06 [0.87-1.30],0.5488904017373868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",20938,1689,1.03 [0.95-1.12],0.4468869187881005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",19323,74,0.96 [0.63-1.45],0.8328625282900309
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Smoking dependency,23102,1021,0.98 [0.88-1.09],0.7372824998021376
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",20435,1186,0.99 [0.90-1.10],0.9142043565804304
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter V Mental and behavioural disorders,Vascular dementia,23024,91,1.07 [0.76-1.50],0.713512301833723
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Alzheimer disease,23440,314,0.91 [0.74-1.13],0.3878039147895457
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Alzheimer√ïs disease (Atypical or mixed), excluding more controls",16055,53,0.89 [0.52-1.54],0.6770803643219736
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Bell's palsy,21599,71,0.84 [0.53-1.33],0.4575969262505986
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,22078,550,1.17 [1.04-1.31],0.0101317802901151
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral cysts,23099,187,1.07 [0.86-1.34],0.5372571617878958
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,23380,234,0.94 [0.74-1.19],0.5907224205963229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Circumscribed brain atrophy,23031,38,0.91 [0.50-1.65],0.7489614635989392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Diseases of the myoneural junction and muscle,23429,40,0.76 [0.39-1.48],0.4200950555159473
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Disorders of brain, other and unspecified",22956,44,1.05 [0.66-1.69],0.8342594388842657
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Epilepsy,22207,242,1.12 [0.93-1.34],0.2393910550342569
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,23083,1118,0.98 [0.88-1.08],0.6532925289683192
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Extrapyramidal and movement disorders,23397,303,0.85 [0.68-1.07],0.1635904291014394
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Falls/tendency to fall,22909,2465,1.04 [0.98-1.11],0.1885117094023601
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Generalized epilepsy,23129,42,1.08 [0.67-1.73],0.7539478371507213
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hemiplegia,23331,185,0.92 [0.71-1.21],0.5681089152707517
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Hydrocephalus,22966,54,0.56 [0.28-1.10],0.0920882640340057
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Inflammatory diseases of the central nervous system,23422,67,0.66 [0.38-1.16],0.1451626550755341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of plantar nerve,21638,110,1.25 [0.98-1.59],0.0673659864652463
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Lesion of ulnar nerve,21584,56,0.73 [0.41-1.31],0.2932118340044294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Memory loss,22914,91,1.09 [0.80-1.50],0.5886096873723812
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Migraine,22393,428,1.01 [0.87-1.18],0.8937483771387995
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",23343,391,1.01 [0.86-1.19],0.8983280517563595
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Motor neuron disease,16141,115,0.80 [0.55-1.17],0.2494883838100894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,23242,119,1.13 [0.88-1.46],0.3397832404953183
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",22726,1198,1.06 [0.97-1.16],0.1715259852025913
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Neurological diseases,22056,3151,1.01 [0.95-1.07],0.8668390842097142
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other and unspecified degenerative diseases of nervous system,23112,119,0.68 [0.45-1.03],0.0664375737972533
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",21886,358,0.95 [0.79-1.14],0.5525072311313486
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,"Other and unspecified polyneuropathies, also in other diseases",23390,192,0.88 [0.67-1.15],0.3400768981021433
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,18956,559,0.94 [0.81-1.10],0.4383365364712357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other diseases of spinal cord,22971,59,1.09 [0.73-1.62],0.6664008640187318
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other disorders of nervous system,23020,108,0.89 [0.62-1.28],0.5198129320986347
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other extrapyramidal and movement disorders in other diseases,23236,142,0.72 [0.50-1.04],0.077317708021868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other facial nerve disorders,21607,79,0.86 [0.56-1.32],0.4969378386931539
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other headache syndromes,22031,66,0.75 [0.45-1.27],0.287759608188965
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other neurological diseases,23342,430,0.99 [0.84-1.16],0.907334875529454
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Other sleep disorders,22305,340,0.89 [0.73-1.08],0.2372879461628419
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Parkinson's disease,23418,144,1.00 [0.76-1.33],0.981205763199072
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Postviral fatigue syndrome,22982,70,1.02 [0.70-1.49],0.9173872500816194
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Restless leg syndrome,23439,76,0.86 [0.55-1.34],0.5095883322230221
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Sleep apnoea,23291,273,0.93 [0.75-1.14],0.4793738665667951
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Small fibre neuropathy,23231,33,1.09 [0.65-1.83],0.7450575733285489
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Systemic atrophies primarily affecting the central nervous system,23430,140,0.74 [0.52-1.06],0.105142041543613
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Trigeminal neuralgia,21588,60,1.00 [0.65-1.54],0.9991010736819116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Unspecific neurodegenerative disorder,23440,317,0.92 [0.75-1.13],0.4282839849281344
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VI Diseases of the nervous system,Vascular dementia (undefined),22984,88,1.06 [0.75-1.50],0.755431150864821
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Amblyopia ex anopsia,22937,94,0.97 [0.68-1.39],0.8797605670673927
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Astigmatism,23044,421,1.07 [0.92-1.24],0.396773497917294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,23315,142,1.14 [0.88-1.47],0.3258953254998837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Blepharochalasis,22494,51,1.08 [0.71-1.65],0.713560584336078
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,22489,46,0.96 [0.58-1.57],0.8654346185998831
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Conjunctivitis (acute, non atopic)",23332,57,0.76 [0.43-1.33],0.3368940280119747
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Corneal degeneration,23201,148,0.89 [0.65-1.22],0.4768239668607528
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic nephropathy, excluding more controls",1432,28,1.14 [0.63-2.06],0.6589291931057257
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic neuropathy,1721,53,0.91 [0.56-1.48],0.7010615794263079
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diplopia,22927,84,1.05 [0.74-1.48],0.8008101407402082
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,23291,900,1.06 [0.95-1.18],0.3005765662721568
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",23080,637,1.01 [0.89-1.15],0.8423001115445842
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,22703,260,0.99 [0.81-1.22],0.937763938945787
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",23366,743,1.05 [0.93-1.18],0.4150658681701563
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of optic nerve and visual pathways,23428,61,1.14 [0.79-1.64],0.490987159556462
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of refraction and accommodation,23299,676,1.09 [0.97-1.23],0.1380328679524155
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of sclera, cornea, iris and ciliary body",23402,349,0.95 [0.78-1.15],0.5914431708198418
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of vitreous body,23356,177,1.07 [0.84-1.35],0.5894796558730804
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ectropion of eyelid,22478,35,1.03 [0.60-1.79],0.9039141438575578
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Entropion and trichiasis of eyelid,22483,40,0.78 [0.41-1.52],0.4716816506256984
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Epiphora,22504,61,0.91 [0.57-1.45],0.7035625820325312
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,23365,605,0.96 [0.84-1.11],0.6180658927990564
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma suspect,22904,144,0.99 [0.75-1.32],0.9628790703697188
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Hypermetropia,22679,56,0.93 [0.58-1.51],0.777758609705533
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Iridocyclitis,23138,85,1.06 [0.75-1.49],0.7514936236561552
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Keratitis,23326,273,0.89 [0.71-1.11],0.3014633992592284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Myopia,22805,182,1.19 [0.98-1.45],0.0843921933913621
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified disorders of vitreous body,23292,113,1.05 [0.78-1.42],0.7449947290758487
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,23154,394,0.94 [0.78-1.12],0.4753978120343667
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified visual disturbances,22977,134,1.10 [0.85-1.43],0.4647590917679143
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,21910,2177,1.00 [0.93-1.08],0.961949288395936
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of cornea,23295,242,0.92 [0.73-1.16],0.4855902231655451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eye and adnexa,23418,140,1.11 [0.86-1.42],0.4322545644508961
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,22769,326,0.98 [0.81-1.18],0.8271941022820019
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of iris and ciliary body,23107,54,0.88 [0.52-1.48],0.6257243992802122
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of optic [2nd] nerve and visual pathways,23415,48,1.23 [0.84-1.79],0.2849818050279433
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other inflammation of eyelid,22527,84,1.25 [0.95-1.65],0.110125816543608
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,22570,127,1.03 [0.78-1.37],0.8107869103729364
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified retinal disorders,22483,92,0.88 [0.59-1.31],0.5374907753015717
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other strabismus,22681,58,0.72 [0.41-1.27],0.2595533504168409
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Other, unspecified and serous retinal detachments",22447,56,0.91 [0.56-1.48],0.6944264694016788
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Primary angle-closure glaucoma,22860,100,0.98 [0.69-1.37],0.8933423309172515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Primary open-angle glaucoma, strict",22912,152,0.76 [0.54-1.07],0.1170452450649751
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Ptosis of eyelid,22553,110,0.87 [0.60-1.25],0.4458090141861032
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal detachment with retinal break,22470,79,1.30 [1.00-1.68],0.0472496852753282
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Retinal vascular occlusion,22450,59,1.04 [0.68-1.59],0.8524902476470837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,21515,1782,0.99 [0.92-1.08],0.8897781886264231
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Stenosis and insufficiency of lacrimal passages,22521,78,0.91 [0.60-1.37],0.6528532659201005
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,23218,375,1.05 [0.89-1.23],0.5966830226296644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual field defects,22880,37,1.21 [0.77-1.89],0.4095123020490568
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B","Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual impairment including blindness (binocular or monocular),22986,143,1.07 [0.82-1.39],0.6187723391075681
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Benign paroxysmal vertigo,23222,96,0.75 [0.49-1.16],0.1972786303201404
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of external ear,23401,92,1.10 [0.81-1.49],0.5331156154436437
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Diseases of middle ear and mastoid,23338,123,0.85 [0.61-1.20],0.3663547325802444
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Labyrinthitis,23186,60,0.86 [0.52-1.41],0.5426215070736828
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,M¬éni¬ère disease,23189,63,1.28 [0.95-1.73],0.1031091205373322
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other disorders of ear,23347,683,1.05 [0.93-1.19],0.4150374932211729
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Other specified/unspecified hearing loss,23133,469,1.03 [0.89-1.20],0.7049235729861085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Sensorineural hearing loss,22762,98,1.05 [0.76-1.46],0.7661120510593674
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter VIII Diseases of the ear and mastoid process,Tinnitus,22738,74,1.42 [1.12-1.81],0.0039930409601229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute pharyngitis,23202,74,0.87 [0.56-1.35],0.5354414588177343
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections,23331,203,0.92 [0.72-1.18],0.5276890395615202
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Acute upper respiratory infections of multiple and unspecified sites,23184,56,1.12 [0.76-1.64],0.577622195092383
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza,22001,107,1.11 [0.83-1.48],0.4783739542285177
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,All influenza (not pneumonia),22000,106,1.12 [0.84-1.49],0.428765176412644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic asthma (mode),16666,115,1.17 [0.91-1.51],0.2285316692525105
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Allergic rhinitis,23318,242,0.85 [0.66-1.08],0.1841243919754205
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",18198,1803,0.96 [0.89-1.04],0.3650319757519141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",18331,1780,0.96 [0.88-1.04],0.2863059884968622
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bacterial pneumonia (organism specified),23088,114,1.10 [0.83-1.45],0.5182443681729632
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bacterial pneumonia, not elsewhere classified",21956,62,0.92 [0.58-1.46],0.7389614493355077
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Bronchiectasis,20226,343,1.14 [0.97-1.33],0.108417288130837
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Bronchitis, not specified as acute or chronic",19942,59,0.66 [0.36-1.20],0.1702057182412981
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,22450,2567,0.97 [0.91-1.04],0.4253751230315934
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Chronic rhinitis, nasopharyngitis and pharyngitis",22347,57,1.03 [0.68-1.57],0.8783664273204972
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Chronic sinusitis,22413,123,1.00 [0.74-1.34],0.9777294027070724
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",23297,882,0.86 [0.75-0.97],0.0186111031195339
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Deviated nasal septum,22353,63,0.72 [0.42-1.24],0.2386034057494823
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Diseases of the respiratory system,21648,4401,0.97 [0.92-1.02],0.2760212906312801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",22580,290,0.98 [0.80-1.19],0.8311489896683685
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Early onset COPD,22692,277,0.96 [0.79-1.17],0.6918341474844542
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Emphysema,20108,225,1.00 [0.80-1.24],0.9670195184777028
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,21994,193,1.18 [0.97-1.45],0.0976797536171266
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Influenza and pneumonia,23274,1380,1.00 [0.91-1.09],0.9750894238350616
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Interstitial lung disease,22030,229,1.16 [0.96-1.40],0.1138559500789782
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Later onset COPD,22651,605,0.80 [0.68-0.95],0.0106866569769035
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Lung diseases due to external agents,23434,188,0.82 [0.62-1.10],0.1951528259237707
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Nasal polyp,22348,58,0.90 [0.56-1.45],0.6764965517693311
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,23241,796,0.99 [0.88-1.12],0.8507801416065436
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of pleura,23280,1490,0.97 [0.88-1.06],0.4608516536888464
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,22961,671,0.97 [0.85-1.10],0.6415768348779183
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other pleural conditions,21823,33,1.28 [0.85-1.94],0.2345303799804458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,23368,290,1.14 [0.97-1.35],0.1208344035705107
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,23360,1017,0.92 [0.82-1.04],0.175786742429597
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural effusion,22498,708,0.99 [0.87-1.12],0.8317489474401505
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pleural plaque,21829,39,0.88 [0.48-1.60],0.6735675796993958
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",23068,1174,0.98 [0.88-1.08],0.6479363803192613
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumonitis due to solids and liquids,23409,163,0.84 [0.61-1.14],0.2618872826754235
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pneumothorax,21877,87,1.11 [0.81-1.53],0.5053440987781591
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pollen allergy,23415,203,0.90 [0.69-1.16],0.400155305235546
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Pulmonary oedema,23131,53,0.93 [0.56-1.53],0.7743530025360182
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Respiratory insufficiency,16592,41,0.62 [0.29-1.35],0.2319875799803176
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,23222,777,0.99 [0.88-1.12],0.9186518454658364
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vasomotor and allergic rhinitis,22532,242,0.84 [0.66-1.08],0.1753722819129219
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Viral pneumonia,22073,179,0.99 [0.77-1.27],0.9360689486342144
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,"Viral pneumonia (unknown virus, not influenza)",23097,141,1.02 [0.77-1.34],0.8945126879500515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter X Diseases of the respiratory system,Vocal cord dysfunction,11304,90,0.81 [0.52-1.27],0.3586422932137639
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,16784,33,0.83 [0.41-1.65],0.5881334691874064
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute appendicitis,23275,120,1.13 [0.88-1.46],0.3452159232511611
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute gastritis,17602,70,1.29 [0.97-1.70],0.0764802867848366
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute pancreatitis,21486,137,0.93 [0.68-1.26],0.6219486215880723
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Acute peritonitis,22952,71,0.96 [0.63-1.45],0.8357922996916975
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Alcoholic liver disease,22699,30,1.23 [0.78-1.93],0.377468813921213
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Barrett oesophagus,17830,298,0.95 [0.78-1.16],0.6239255466942155
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",21417,68,0.89 [0.57-1.41],0.6337742471483836
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",23077,68,0.89 [0.56-1.41],0.6211586961628968
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholecystitis,21499,150,0.85 [0.62-1.17],0.3163075738084183
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Cholelithiasis,22375,1026,0.94 [0.85-1.05],0.3013048569444683
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic gastritis,17817,285,0.96 [0.79-1.18],0.7248655433320528
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Chronic pancreatitis,21383,34,1.02 [0.58-1.78],0.9542431480140584
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",23370,63,0.79 [0.47-1.32],0.3708018706669825
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Coeliac disease,22133,126,1.30 [1.05-1.59],0.013693268748043
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Collagenous colitis,21817,94,0.83 [0.56-1.25],0.3831352106776683
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,23321,138,1.04 [0.80-1.35],0.7711302376990208
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Constipation,23148,1449,0.94 [0.86-1.03],0.2161429358336483
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn disease,21795,72,1.02 [0.70-1.49],0.9082708381665155
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",23127,49,1.24 [0.86-1.77],0.2514095795008204
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Crohn's disease NAS,21797,74,0.91 [0.60-1.38],0.6528565565817791
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Dental caries,22724,200,1.03 [0.83-1.30],0.7654690020387512
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diaphragmatic hernia,22055,2097,0.99 [0.92-1.06],0.757836815834868
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of appendix,23312,157,1.07 [0.85-1.36],0.554365076849074
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of liver,23354,685,0.91 [0.79-1.04],0.1738028704228531
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",21482,3950,1.00 [0.95-1.06],0.8584016751087673
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",23031,507,1.03 [0.89-1.19],0.6829436204904682
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of peritoneum,23333,452,1.00 [0.85-1.17],0.977586276596484
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,22627,103,0.84 [0.57-1.23],0.3703826858014288
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of salivary glands,22495,54,0.89 [0.54-1.47],0.6606470695747269
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of the digestive system,23185,1178,1.04 [0.95-1.14],0.403045826590295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diseases of tongue,22501,91,1.43 [1.16-1.76],0.0006461817985775
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",22712,1363,0.95 [0.86-1.04],0.2709602135087455
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Diverticular disease of intestine,19483,2732,1.01 [0.95-1.08],0.6538352848217418
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Duodenal ulcer,17647,115,0.85 [0.59-1.22],0.3827412535791882
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",23392,96,0.91 [0.63-1.32],0.6288515851754429
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Embedded and impacted teeth,23355,56,1.06 [0.71-1.58],0.7765573436823718
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,22750,81,0.84 [0.55-1.30],0.4392360677528103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,16851,100,1.06 [0.78-1.44],0.6974725687161507
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Functional dyspepsia,18104,572,1.03 [0.90-1.18],0.6662467663752284
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastric ulcer,17832,300,0.94 [0.77-1.16],0.5680895890163393
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,19927,2395,0.99 [0.93-1.06],0.8707309518231073
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,17943,411,1.00 [0.85-1.18],0.9928277863004074
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gastrointestinal diseases,18343,7184,1.02 [0.98-1.06],0.2385122404172107
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,GI-bleeding,22945,938,1.00 [0.90-1.12],0.9801335464284602
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Gingivitis and periodontal diseases,22586,62,1.15 [0.81-1.62],0.438156089423242
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Haemorrhoids and perianal venous thrombosis,17579,1078,0.92 [0.83-1.03],0.1557936874515191
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",22703,34,1.02 [0.58-1.81],0.9373737699532432
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Hernia,22427,2469,0.98 [0.91-1.04],0.4787028397489254
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impacted teeth,23363,51,1.14 [0.78-1.67],0.4899656941808678
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Impaction of intestines,16810,59,0.81 [0.48-1.37],0.4398093641860074
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Inguinal hernia,20104,146,1.12 [0.88-1.42],0.3688665844416378
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal adhesions without obstruction,16835,84,1.04 [0.73-1.47],0.8328811222757369
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Intestinal malabsorption,22159,152,1.24 [1.01-1.51],0.0402851621996841
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Irritable bowel syndrome,17447,696,0.95 [0.83-1.08],0.4436576815645524
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,23431,294,0.85 [0.68-1.06],0.1564369885069877
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,22423,700,1.05 [0.93-1.18],0.432570136752853
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,22664,941,1.07 [0.97-1.18],0.2068034168435829
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophageal obstruction,17664,132,1.02 [0.78-1.35],0.8701372476565121
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oesophagitis,18024,492,1.05 [0.91-1.21],0.4970798302293444
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Oral lichen ruber planus,23399,142,0.94 [0.70-1.26],0.6699318038123796
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other and unspecified abdominal hernia,20009,51,0.86 [0.51-1.47],0.5848646476010825
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,17809,1058,1.04 [0.94-1.15],0.4487704476062165
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of biliary tract,21600,251,0.93 [0.74-1.17],0.5525725851164577
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of gallbladder,21513,164,1.05 [0.82-1.34],0.6915211213501965
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestine,18097,1346,1.03 [0.94-1.12],0.5733454021815483
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of intestines,21597,4846,1.01 [0.97-1.06],0.579797579849481
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,22500,205,0.97 [0.76-1.23],0.7839777120371609
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of liver,23238,569,0.88 [0.75-1.03],0.1162347808139451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of oesophagus,18038,506,0.96 [0.82-1.11],0.5696452791399504
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of pancreas,21483,134,0.83 [0.58-1.17],0.2792348095723191
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of peritoneum,23279,398,1.01 [0.85-1.18],0.9454250898382464
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,18457,925,1.04 [0.94-1.16],0.4136771857159814
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other diseases of the digestive system,22962,955,0.99 [0.89-1.11],0.9246490201150188
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,22674,150,1.07 [0.84-1.38],0.5790523567783277
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other functional intestinal disorders,18251,1500,0.97 [0.89-1.06],0.4908968530524654
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),19329,1797,1.00 [0.93-1.08],0.954186759309877
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,22756,87,1.07 [0.77-1.48],0.6941845834592572
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,22554,831,1.04 [0.94-1.16],0.4345234382301924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",17034,283,0.86 [0.68-1.08],0.1976906356467519
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Palatinal maxillary canine,23346,65,1.08 [0.76-1.55],0.6597641777199229
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,17173,422,0.93 [0.78-1.10],0.3844168144649813
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",22125,118,1.15 [0.89-1.49],0.2930917770240729
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Recurring oral aphthae,23432,66,0.83 [0.51-1.35],0.4532854851009251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Stomatitis and related lesions,22524,118,1.00 [0.73-1.35],0.9844703936408428
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Toxic colitis,21778,55,1.24 [0.87-1.77],0.2423214472223128
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcer of oesophagus,17739,207,0.86 [0.66-1.12],0.2688871477134508
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ulcerative colitis,21869,146,1.10 [0.86-1.40],0.4403653508378127
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",21845,122,1.07 [0.82-1.41],0.6130932159938333
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Umbilical hernia,20108,150,0.66 [0.45-0.95],0.0276231760690891
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Vascular disorders of the intestines,16916,165,0.87 [0.65-1.17],0.3712225046548173
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Ventral hernia,20167,209,0.99 [0.79-1.25],0.9407030715090382
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XI Diseases of the digestive system,Volvulus,16825,74,0.93 [0.62-1.41],0.7360470198664586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Actinic keratosis,23367,211,1.10 [0.90-1.35],0.3576060506340943
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Arthropathic psoriasis,23166,73,1.03 [0.71-1.49],0.8863825474560346
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,21692,190,0.95 [0.74-1.22],0.7088749149033451
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,22969,536,0.94 [0.80-1.09],0.4009068304669518
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",22561,128,1.24 [0.99-1.54],0.0627077087435073
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Decubitus ulcer and pressure area,21773,271,0.93 [0.75-1.16],0.5404721260145093
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis,23171,241,1.01 [0.82-1.25],0.910968424783954
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,23342,412,1.10 [0.95-1.27],0.2121688867013453
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis due to substances taken internally,22972,42,1.27 [0.87-1.85],0.2149615251220489
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,22060,2703,1.00 [0.94-1.07],0.9703078652284298
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,23046,406,1.10 [0.95-1.27],0.2136848081690042
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,22918,278,1.15 [0.98-1.36],0.0913337812166207
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,23159,726,0.96 [0.85-1.09],0.5467873608681988
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Lichen planus, including avohilmo",23421,64,1.00 [0.66-1.50],0.983234628294746
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Lupus erythematosus,21588,86,0.66 [0.40-1.08],0.0966940552902228
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,22680,40,0.80 [0.42-1.52],0.4997312781635117
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified dermatitis,23157,227,1.03 [0.83-1.27],0.8048545393900717
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,21853,351,1.04 [0.88-1.23],0.6559961511597241
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified epidermal thickening,21548,46,0.87 [0.50-1.53],0.6278397406807135
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified erythematous conditions,23348,67,1.33 [1.01-1.75],0.0387501397634063
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified local infections of skin and subcutaneous tissue,22564,131,0.92 [0.67-1.26],0.6122120919430236
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,23242,149,1.03 [0.79-1.34],0.8098510343938772
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other contact dermatitis,22972,42,1.06 [0.64-1.74],0.8310363219320065
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of pigmentation,21557,55,1.31 [0.95-1.81],0.1015896179940388
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,22858,1356,0.97 [0.89-1.07],0.5821334314108626
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",21884,382,1.00 [0.84-1.18],0.9580257416847688
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Other epidermal thickening,21552,50,0.86 [0.50-1.48],0.5822217495069082
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,23367,274,1.02 [0.84-1.24],0.8561884747124873
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Pruritus,23003,73,1.22 [0.90-1.65],0.2081808772937042
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,23306,213,1.01 [0.81-1.27],0.8987858595786365
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,23393,237,1.11 [0.92-1.34],0.2688331209451303
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,21642,140,1.00 [0.76-1.32],0.9739792757776512
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,21727,225,1.07 [0.87-1.31],0.5306960843559209
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,23382,226,1.10 [0.91-1.34],0.3280196864156642
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,"Ulcer of lower limb, not elsewhere classified",21673,171,0.95 [0.72-1.24],0.6925944768598672
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XII Diseases of the skin and subcutaneous tissue,Urticaria and erythema,23407,126,1.32 [1.08-1.62],0.0073196171334965
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Adhesive capsulitis of shoulder,19998,113,0.95 [0.68-1.31],0.7360957082645292
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,21287,5459,0.98 [0.94-1.03],0.4626815566154426
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,20100,4272,0.99 [0.94-1.04],0.7357926925050006
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Bursitis of shoulder,19950,65,1.07 [0.73-1.57],0.7334962110654103
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,20115,129,0.97 [0.71-1.31],0.8338085750012085
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,20165,179,1.01 [0.79-1.29],0.9539672628706658
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Chondropathies,23197,98,0.83 [0.56-1.23],0.3571511366935982
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Collapsed vertebra, not elsewhere classified",20086,100,0.85 [0.58-1.26],0.4265001592888862
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,17019,1191,0.97 [0.88-1.08],0.579409420400584
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",23308,196,0.91 [0.70-1.18],0.4612902598065129
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,20493,507,0.97 [0.83-1.13],0.6960335495287894
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,19695,6957,0.99 [0.95-1.03],0.74097215525569
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,20992,116,0.99 [0.72-1.35],0.9348969782647027
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of muscles,20002,117,0.86 [0.61-1.24],0.4247037218934529
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,20476,591,0.94 [0.82-1.09],0.4240464523950301
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,22563,2577,0.99 [0.93-1.06],0.7958311142478754
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,20037,152,0.88 [0.65-1.19],0.4112978453497341
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibromyalgia,20222,337,1.03 [0.86-1.22],0.7510211246321491
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,20038,153,1.07 [0.84-1.37],0.5655702638362355
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Giant cell arteritis,22589,94,1.05 [0.76-1.46],0.7718550758445306
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,17445,1617,0.97 [0.89-1.06],0.4836706425984408
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,16004,176,0.74 [0.53-1.03],0.0757633224662241
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",23427,173,0.77 [0.56-1.06],0.1104327829643586
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,15921,93,0.92 [0.63-1.34],0.6585653934825667
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),16324,496,0.94 [0.80-1.10],0.4097654321397809
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,20174,289,0.96 [0.79-1.18],0.7247319223187688
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,16376,548,1.04 [0.90-1.19],0.6016880698656941
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Kyphosis,20044,58,1.06 [0.70-1.60],0.7878403856978592
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,20597,611,0.87 [0.75-1.02],0.0815223537433778
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,20272,286,0.97 [0.79-1.19],0.7680233697084903
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,16336,508,1.03 [0.89-1.19],0.6747334025288441
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Myalgia,19960,75,0.96 [0.64-1.43],0.8474764739780392
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Neuralgia and neuritis, unspecified",19946,61,1.36 [1.02-1.80],0.0339965164849211
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteomyelitis,20921,45,0.96 [0.58-1.60],0.8888455850201656
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,23036,2160,1.06 [0.99-1.13],0.1043929890243889
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,22433,1557,1.10 [1.02-1.19],0.0096285213264779
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",23262,509,1.03 [0.89-1.19],0.6588586825217251
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,18434,2606,1.00 [0.94-1.07],0.9282738491879904
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other articular cartilage disorders,15890,62,0.73 [0.43-1.27],0.2658485830447897
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other bursopathies,19975,90,1.34 [1.06-1.70],0.0152429107262213
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other crystal arthropathies,15870,42,0.87 [0.47-1.60],0.6496121514621266
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),16006,178,0.95 [0.73-1.23],0.6832407906338515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,21132,256,0.94 [0.76-1.18],0.6083085187748515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone density and structure,21364,488,0.91 [0.77-1.08],0.2811559534405338
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of the musculoskeletal system and connective tissue,23418,95,0.91 [0.63-1.32],0.6163548597484778
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",21732,1746,1.00 [0.92-1.08],0.9607883029721676
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,19997,112,0.97 [0.71-1.34],0.8577220153578767
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),16028,200,0.85 [0.64-1.12],0.2342849424845483
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,20686,700,1.03 [0.91-1.16],0.6722720712116439
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,18028,2200,0.95 [0.88-1.02],0.1628692015089091
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other necrotizing vasculopathies,22609,114,1.03 [0.76-1.39],0.8437552566690566
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other psoriatic arthropathies,23422,73,1.03 [0.71-1.50],0.8566089209649036
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,19950,65,0.84 [0.52-1.36],0.4769669570671794
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",21153,1268,1.02 [0.93-1.12],0.6766193833431877
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified disorders of muscle,19957,72,0.97 [0.65-1.46],0.8926961499186755
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,17530,1702,0.96 [0.88-1.04],0.3331751259064006
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,21004,128,1.02 [0.77-1.35],0.8938144339139532
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of synovium and tendon +Other specified/unspecified bursopathies,19932,47,0.72 [0.38-1.35],0.3052850162019466
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified inflammatory spondylopathies,20156,170,1.11 [0.88-1.40],0.3700048717868357
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,20377,492,1.06 [0.92-1.22],0.4168432021621616
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,22937,442,0.89 [0.75-1.07],0.2149508381585295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,20544,558,0.99 [0.85-1.14],0.8694536281172482
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,23274,492,1.02 [0.88-1.18],0.7829693675288582
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified seropositive rheumatoid arthritis,23414,59,0.78 [0.45-1.34],0.3665631569470098
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,20080,195,0.89 [0.69-1.16],0.4058640153811126
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,17958,785,0.97 [0.85-1.09],0.5824293351800717
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,20453,568,0.91 [0.78-1.06],0.2152776878178978
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],19989,104,0.83 [0.56-1.22],0.3365404247263875
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Polyarthritis, unspecified",15898,70,1.07 [0.73-1.58],0.7158645515110815
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,18082,2254,0.97 [0.90-1.05],0.4770037138471533
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,16546,718,0.95 [0.83-1.08],0.4324887750216181
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polymyalgia rheumatica,22747,252,0.80 [0.62-1.04],0.0953788536319353
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Postprocedural musculoskeletal disorders, not elsewhere classified",23392,69,0.91 [0.58-1.41],0.6637306830494403
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Primary gonarthrosis, bilateral",21472,47,0.94 [0.55-1.60],0.8161599436514786
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Psoriatic arthropathies,15902,74,1.01 [0.69-1.49],0.9455307480994092
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Radiculopathy,20084,98,0.93 [0.65-1.34],0.6945042252565287
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,16341,513,1.01 [0.87-1.18],0.8584905430977688
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,20165,280,1.06 [0.88-1.28],0.5322211343781116
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,20234,248,1.01 [0.82-1.25],0.9070726870343444
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Scoliosis,20226,240,0.99 [0.79-1.23],0.9070003381540216
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Seronegative rheumatoid arthritis,18069,74,0.82 [0.52-1.31],0.4142833867767621
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Seropositive rheumatoid arthritis, wide",23420,65,0.74 [0.44-1.26],0.2727060297994128
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,20432,547,1.01 [0.88-1.16],0.9093022286508944
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [Sj¬ögren],22642,147,1.03 [0.79-1.34],0.8303613902741612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,22307,2422,1.01 [0.94-1.08],0.8255425586905621
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",20022,137,0.88 [0.64-1.21],0.4379134169578808
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,20460,474,1.03 [0.88-1.19],0.7266700096431924
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondyloarthritis,21926,221,1.04 [0.84-1.29],0.7006486128087746
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylolisthesis/Spondylolysis,20201,215,0.99 [0.79-1.25],0.941356160140986
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,21462,1476,1.00 [0.91-1.09],0.9416227599568148
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,20989,1003,0.97 [0.87-1.09],0.6379589732184427
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Synovial cyst of popliteal space [Baker],19940,55,1.57 [1.24-1.98],0.0001544886933665
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,22705,210,1.08 [0.87-1.33],0.4760060799063788
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,20054,169,0.92 [0.70-1.22],0.5742839421327458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trochanteric bursitis,20001,116,0.84 [0.59-1.21],0.3572104542857363
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIII Diseases of the musculoskeletal system and connective tissue,Wrist or foot drop (acquired),15871,43,0.70 [0.35-1.39],0.3093290593488221
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Acute renal failure,22616,1008,1.05 [0.95-1.16],0.3546730674466783
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),17561,87,1.08 [0.78-1.49],0.6401366319881249
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,22849,97,1.09 [0.81-1.47],0.5537290393252612
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,23309,197,0.79 [0.59-1.05],0.1095438040971405
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Calculus of lower urinary tract,23133,21,0.41 [0.13-1.33],0.1367663451966453
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,22747,1139,1.02 [0.92-1.12],0.7577310185036674
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Chronic nephritic syndrome,23301,55,1.09 [0.71-1.68],0.683356723789739
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cyst of kidney,23273,199,1.03 [0.82-1.30],0.8042171768755918
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Cystitis,20713,216,0.89 [0.69-1.15],0.3902650887130861
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Dialysis,21652,44,1.01 [0.62-1.66],0.9576506038588803
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Disorders of breast,23025,273,1.03 [0.85-1.24],0.796042092516879
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Endometriosis,17623,149,1.13 [0.89-1.42],0.308978656880084
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",17808,334,0.99 [0.82-1.18],0.8962580173476945
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Female genital prolapse,18338,864,1.02 [0.91-1.14],0.7473156381265644
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,18232,4209,1.02 [0.97-1.07],0.5238957117519019
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,23299,53,1.23 [0.86-1.75],0.2531307593612801
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Hydronephrosis,21491,178,1.04 [0.82-1.32],0.7452117315280498
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,22963,347,0.86 [0.70-1.05],0.1407639948025607
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Irregular menses,23046,107,1.09 [0.82-1.44],0.5551054331505263
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Menorrhagia,17735,261,0.95 [0.76-1.18],0.6257700551917185
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,20564,67,1.14 [0.81-1.60],0.4668566499802183
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,19554,2080,1.03 [0.96-1.11],0.3852257732665848
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,17590,116,1.02 [0.76-1.37],0.9029553661868364
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other chronic cystitis, drug-induced",23432,56,0.86 [0.52-1.44],0.5732237011302665
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other cystitis, drug-induced",23431,66,0.83 [0.51-1.35],0.4483145466622141
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,22373,1876,1.02 [0.95-1.10],0.5749436398876739
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,20905,408,1.01 [0.86-1.19],0.904556405217651
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of breast,22847,95,1.07 [0.78-1.46],0.6694355696954345
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,23389,315,0.98 [0.81-1.19],0.8537784092930274
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of the genitourinary system,23388,73,0.89 [0.57-1.37],0.582083581253025
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,22102,1605,1.01 [0.93-1.09],0.862929552442711
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,22794,178,0.90 [0.68-1.18],0.4389415408727515
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,17607,133,1.09 [0.84-1.41],0.5275620717048224
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",17803,329,1.11 [0.94-1.30],0.2322073557986035
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,17574,100,1.05 [0.77-1.43],0.7613951264793682
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,17650,176,0.81 [0.59-1.09],0.16641918677272
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,21536,223,1.05 [0.85-1.30],0.6359622083498295
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Other specified disorders of kidney and ureter,23180,106,0.89 [0.62-1.27],0.5107903812920951
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Ovarian cyst,17737,263,1.09 [0.91-1.31],0.3433811167246021
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,17562,88,0.84 [0.56-1.27],0.4020443877664712
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,18013,539,0.95 [0.81-1.10],0.4857904542281416
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal atrophic vaginitis,17612,138,0.92 [0.68-1.25],0.6059825115907294
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,17968,494,1.03 [0.89-1.19],0.7226664217496352
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Recurrent and persistent haematuria,23279,33,0.38 [0.15-1.02],0.0550092062736154
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,23291,1978,1.03 [0.96-1.11],0.4170185274602322
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",21454,141,1.10 [0.86-1.41],0.4663809089979235
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,21689,81,0.95 [0.64-1.42],0.8041118026687404
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,23144,32,0.71 [0.33-1.54],0.3890861168164468
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urethral stricture,20618,121,1.27 [1.01-1.59],0.0374087003907391
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Urolithiasis,23338,226,0.80 [0.61-1.05],0.1095193303982458
GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",Chapter XIV Diseases of the genitourinary system,Uterine polyps,17592,118,0.90 [0.64-1.26],0.537367895012796
